News About: Pharm. Industry
4 listed pharma including Seoul Pharma spend more than 50% of their sales into SG&A
One of 3 listed pharmaceutical companies reportedly send 40% of their sales into selling, general and administrative(SG&A) expenses. Particularly, 4 companies, such as Seoul Pharma, Jin Yang Pharmaceutical, Korea Arli...
Health care providers’ distrust on generics due to Valsartan incident, switching to originals
As carcinogenic N-nitrosodimethylamine is detected in Valsartan ingredients from Chinese and Indian one after another, part of the medical field is researched to prescribe the original drug more.
On the 27th, ‘InterM...
Dong-A ST introduces a new antiviral with Japanese TAKARA BIO INC
Dong-A ST(CEO/President Dae-Shik Eom) announced on the 23rd that they signed an agreement to introduce a new antiviral with a Japanese biotechnology company TAKARA BIO INC(CEO Nakao Koichi), which develops gene and ce...
Ildong Pharmaceutical jointly sells product licenses with Sandoz in Asian-Pacific regions
Ildong Pharmaceutical(CEO Woong-Sup Yoon) will make a strategic alliance with Sandoz, a subsidiary of the global pharmaceutical company Novartis Group.
Ildong Pharmaceutical signed a memorandum of understanding(MOU) ...
Celltrion Healthcare starts to sell biosimilar ‘Herzuma’ in Japan
Celltrion Healthcare announced on the 23rd that they would start to sell the antibody biosimilar ‘Herzuma(generic name: trastuzumab)’ this month in Japan. The Japanese Ministry of Health, Labour and Welfare approved ‘...
T&R Biofab distributes German Merck’s bio-ink products in the world
T&R Biofab, a 3D bioprinting company, announced on the 22nd that they signed a supply agreement of the original equipment manufacturing(OEM) method for the bio-ink developed by German Merck with the company to enter t...
Small and medium pharmas, please guild smart factory with government’s financial support
The Korea Pharmaceutical and Bio-Pharma Manufacturers Association(KPBMA) will take application of participation for the ‘Smart Factory Construction Project’ for the pharmaceutical field.
This is part of the ‘Smart Fa...
Kolon Life Science to ship first supply of ‘Invossa’ to Hong Kong and Macao
Kolon Life Science(CEO Woo-Seok Lee) announced to ship the first supply of the knee arthritis gene therapy ‘INVOSSA-K’ to Hong Kong and Macao.
This shipment is the first supply to Hong Kong and Macao after the agreem...
Listed pharmas’ exports account for 10% of total sales
In order to overcome the limitation of the domestic market, Korean pharmaceutical companies have been active in developing the global market, but the result is not enough.
Also, pharmaceutical companies that are high...
Patent Court gives decision in favor of Layla generics, nullifying its composition patent
The composition patent of ‘Layla(PMG Pharm),’ a natural drug for osteoarthritis making approximately KRW 20 billion sales, received a decision of nullification at the Patent Court.
Mother’s Pharm led the nullificatio...
